TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences Statistics

Total Valuation

TLSI has a market cap or net worth of $184.51 million. The enterprise value is $184.70 million.

Market Cap	184.51M
Enterprise Value	184.70M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TLSI has 49.87 million shares outstanding. The number of shares has increased by 37.59% in one year.

Current Share Class	37.84M
Shares Outstanding	49.87M
Shares Change (YoY)	+37.59%
Shares Change (QoQ)	+15.33%
Owned by Insiders (%)	17.91%
Owned by Institutions (%)	32.98%
Float	27.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.93
Forward PS	3.36
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08

Current Ratio	4.08
Quick Ratio	3.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-52.51%
Return on Invested Capital (ROIC)	-301.29%
Return on Capital Employed (ROCE)	-96.83%
Revenue Per Employee	$327,182
Profits Per Employee	-$297,782
Employee Count	110
Asset Turnover	0.98
Inventory Turnover	1.52

Taxes

Income Tax	-2,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.04% in the last 52 weeks. The beta is 0.48, so TLSI's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-39.04%
50-Day Moving Average	4.82
200-Day Moving Average	4.94
Relative Strength Index (RSI)	30.16
Average Volume (20 Days)	73,544

Short Selling Information

The latest short interest is 582,930, so 1.17% of the outstanding shares have been sold short.

Short Interest	582,930
Short Previous Month	605,277
Short % of Shares Out	1.17%
Short % of Float	2.12%
Short Ratio (days to cover)	12.44

Income Statement

In the last 12 months, TLSI had revenue of $35.99 million and -$32.76 million in losses. Loss per share was -$1.18.

Revenue	35.99M
Gross Profit	30.47M
Operating Income	-30.98M
Pretax Income	-63.97M
Net Income	-32.76M
EBITDA	-30.27M
EBIT	-30.98M
Loss Per Share	-$1.18

Balance Sheet

The company has $26.49 million in cash and $33.66 million in debt, giving a net cash position of -$7.17 million or -$0.14 per share.

Cash & Cash Equivalents	26.49M
Total Debt	33.66M
Net Cash	-7.17M
Net Cash Per Share	-$0.14
Equity (Book Value)	-19.42M
Book Value Per Share	-0.51
Working Capital	28.76M

Cash Flow

In the last 12 months, operating cash flow was -$28.37 million and capital expenditures -$880,000, giving a free cash flow of -$29.25 million.

Operating Cash Flow	-28.37M
Capital Expenditures	-880,000
Free Cash Flow	-29.25M
FCF Per Share	-$0.59

Margins

Gross margin is 84.67%, with operating and profit margins of -86.08% and -86.61%.

Gross Margin	84.67%
Operating Margin	-86.08%
Pretax Margin	-86.61%
Profit Margin	-86.61%
EBITDA Margin	-84.10%
EBIT Margin	-86.08%
FCF Margin	n/a

Dividends & Yields

TLSI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.59%
Shareholder Yield	-37.59%
Earnings Yield	-18.45%
FCF Yield	-16.48%

Analyst Forecast

The average price target for TLSI is $10.90, which is 194.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.90
Price Target Difference	194.60%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	38.74%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2